Literature DB >> 19456832

Genomic diversity of group A rotavirus strains in patients aged 1-36 months admitted for acute watery diarrhoea in northern India: a hospital-based study.

V Mishra1, S Awasthi, V L Nag, R Tandon.   

Abstract

The diversity and capacity of human rotaviruses for rapid evolution and genetic reassortment suggests that rotavirus vaccine should be designed to provide heterotypic protection. The objective of the present study was to provide information on the circulating genotypes of rotavirus and allied baseline epidemiology in Lucknow, India. In a cross-sectional study, the prevalence of rotavirus G-P types was studied in patients aged 1-36 months with acute watery diarrhoea. Various sociodemographic, environmental and clinical factors were assessed as potential predictors of rotavirus infection; 412 patients with acute watery diarrhoea were recruited into the study from September 2004 to April 2008 and rotavirus was identified in 19.2% (79/412) cases using ELISA and PAGE. The genotypes identified were G1 (38.0%), G2 (15.2%), G3 (16.5%), G9 (10.9%), G4 (5.1%) and mixed G types (10.1%). The most common G-P combinations were G1P[8], G3P[6], G1P[6] and G2P[8]. Rotavirus diarrhoea was found to occur throughout the year with a single peak in winter months (November-January). Rotavirus diarrhoea was found to be associated with children not currently breast fed (adjusted OR 2.2, 95% CI 1.3-3.7, p 0.004), children < or =7 months of age (adjusted OR 1.1, 95% CI 1.0-1.1, p 0.002) and children with severe dehydration (adjusted OR 1.8, 95% CI 1.1-3.0, p 0.03) using multivariate logistic regression. A high degree of strain diversity of rotavirus G and P types was detected. Rotavirus was found to be associated with dehydrating diarrhoea, particularly in children aged 0-7 months, placing them at increased risk of mortality.

Entities:  

Mesh:

Year:  2010        PMID: 19456832     DOI: 10.1111/j.1469-0691.2009.02772.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  7 in total

1.  Prevalence and risk factors of diarrhea morbidity among under-five children in India: A systematic review and meta-analysis.

Authors:  Enakshi Ganguly; Pawan K Sharma; Clareann H Bunker
Journal:  Indian J Child Health (Bhopal)       Date:  2015-11-06

2.  Global seasonality of rotavirus disease.

Authors:  Manish M Patel; Virginia E Pitzer; Wladimir J Alonso; David Vera; Ben Lopman; Jacqueline Tate; Cecile Viboud; Umesh D Parashar
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

3.  Seasonality of rotavirus in South Asia: a meta-analysis approach assessing associations with temperature, precipitation, and vegetation index.

Authors:  Jyotsna S Jagai; Rajiv Sarkar; Denise Castronovo; Deepthi Kattula; Jesse McEntee; Honorine Ward; Gagandeep Kang; Elena N Naumova
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

4.  Aetiology of childhood viral gastroenteritis in Lucknow, north India.

Authors:  Shilpi Gupta; K P Singh; Amita Jain; Shilpi Srivastava; Vishwajeet Kumar; Mastan Singh
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

5.  Global occurrence and emission of rotaviruses to surface waters.

Authors:  Nicholas M Kiulia; Nynke Hofstra; Lucie C Vermeulen; Maureen A Obara; Gertjan Medema; Joan B Rose
Journal:  Pathogens       Date:  2015-05-13

6.  Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India.

Authors:  C P Girish Kumar; Sidhartha Giri; Mamta Chawla-Sarkar; Varanasi Gopalkrishna; Shobha D Chitambar; Pratima Ray; S Venkatasubramanian; Biswajyoti Borkakoty; Subarna Roy; Jyothi Bhat; Bhagirathi Dwibedi; Vijayachari Paluru; Pradeep Das; Rashmi Arora; Gagandeep Kang; Sanjay M Mehendale
Journal:  Vaccine       Date:  2020-11-07       Impact factor: 3.641

7.  A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.

Authors:  Raches Ella; Radhika Bobba; Sanjay Muralidhar; Sudhir Babji; Krishna Mohan Vadrevu; Maharaj Kishan Bhan
Journal:  Hum Vaccin Immunother       Date:  2018-04-12       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.